These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36829233)

  • 21. TGF-β Blood Levels Distinguish Between Influenza A (H1N1)pdm09 Virus Sepsis and Sepsis due to Other Forms of Community-Acquired Pneumonia.
    Rendón-Ramirez EJ; Ortiz-Stern A; Martinez-Mejia C; Salinas-Carmona MC; Rendon A; Mata-Tijerina VL; Rosas-Taraco AG
    Viral Immunol; 2015 Jun; 28(5):248-54. PubMed ID: 25923384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia.
    Suberviola B; Castellanos-Ortega A; Llorca J; Ortiz F; Iglesias D; Prieto B
    Swiss Med Wkly; 2012; 142():w13542. PubMed ID: 22430899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis identified potential age-associated prognostic biomarkers in pneumonia-derived paediatric sepsis.
    Luo T; Yan H; Li X; Deng Y; Huang J; Li L; Xiao Z; Lu X
    Proteomics Clin Appl; 2022 May; 16(3):e2100036. PubMed ID: 34822739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Hyperferritinemia With Distinct Host Response Aberrations in Patients With Community-Acquired Pneumonia.
    Brands X; van Engelen TSR; de Vries FMC; Haak BW; Klarenbeek AM; Kanglie MMNP; van den Berk IAH; Schuurman AR; Peters-Sengers H; Otto NA; Faber DR; Lutter R; Scicluna BP; Stoker J; Prins JM; Joost Wiersinga W; van der Poll T
    J Infect Dis; 2022 Jun; 225(11):2023-2032. PubMed ID: 35100411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic potential of circulating cell-free microRNAs for community-acquired pneumonia and pneumonia-related sepsis.
    Hermann S; Brandes F; Kirchner B; Buschmann D; Borrmann M; Klein M; Kotschote S; Bonin M; Reithmair M; Kaufmann I; Schelling G; Pfaffl MW
    J Cell Mol Med; 2020 Oct; 24(20):12054-12064. PubMed ID: 32916773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 plasma proteome reveals novel temporal and cell-specific signatures for disease severity and high-precision disease management.
    Iosef C; Martin CM; Slessarev M; Gillio-Meina C; Cepinskas G; Han VKM; Fraser DD
    J Cell Mol Med; 2023 Jan; 27(1):141-157. PubMed ID: 36537107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progranulin signaling in sepsis, community-acquired bacterial pneumonia and COVID-19: a comparative, observational study.
    Brandes F; Borrmann M; Buschmann D; Meidert AS; Reithmair M; Langkamp M; Pridzun L; Kirchner B; Billaud JN; Amin NM; Pearson JC; Klein M; Hauer D; Gevargez Zoubalan C; Lindemann A; Choukér A; Felbinger TW; Steinlein OK; Pfaffl MW; Kaufmann I; Schelling G
    Intensive Care Med Exp; 2021 Sep; 9(1):43. PubMed ID: 34476621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection.
    Bauer W; Weber M; Diehl-Wiesenecker E; Galtung N; Prpic M; Somasundaram R; Tauber R; Schwenk JM; Micke P; Kappert K
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of inflammation and the etiology of sepsis.
    Grondman I; Pirvu A; Riza A; Ioana M; Netea MG
    Biochem Soc Trans; 2020 Feb; 48(1):1-14. PubMed ID: 32049312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Ferritin as Marker of Macrophage Activation-Like Syndrome in Critically Ill Patients With Community-Acquired Pneumonia.
    Brands X; de Vries FMC; Uhel F; Haak BW; Peters-Sengers H; Schuurman AR; van Engelen TSR; Lutter R; Cremer OL; Bonten MJ; Schultz MJ; Scicluna BP; van der Poll T;
    Crit Care Med; 2021 Nov; 49(11):1901-1911. PubMed ID: 33935163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid metabolism impairment in patients with sepsis secondary to hospital acquired pneumonia, a proteomic analysis.
    Sharma NK; Ferreira BL; Tashima AK; Brunialti MKC; Torquato RJS; Bafi A; Assuncao M; Azevedo LCP; Salomao R
    Clin Proteomics; 2019; 16():29. PubMed ID: 31341447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble RAGE as a severity marker in community acquired pneumonia associated sepsis.
    Narvaez-Rivera RM; Rendon A; Salinas-Carmona MC; Rosas-Taraco AG
    BMC Infect Dis; 2012 Jan; 12():15. PubMed ID: 22264245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predicting sepsis severity at first clinical presentation: The role of endotypes and mechanistic signatures.
    Baghela A; Pena OM; Lee AH; Baquir B; Falsafi R; An A; Farmer SW; Hurlburt A; Mondragon-Cardona A; Rivera JD; Baker A; Trahtemberg U; Shojaei M; Jimenez-Canizales CE; Dos Santos CC; Tang B; Bouma HR; Cohen Freue GV; Hancock REW
    EBioMedicine; 2022 Jan; 75():103776. PubMed ID: 35027333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of Delirium in a Low-Risk Community-Acquired Pneumonia-Induced Sepsis.
    Tomasi CD; Vuolo F; Generoso J; Soares M; Barichello T; Quevedo J; Ritter C; Dal-Pizzol F
    Mol Neurobiol; 2017 Jan; 54(1):722-726. PubMed ID: 26768428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of sepsis inflammatory endotypes using circulatory proteins in patients with severe infection: a prospective cohort study.
    Ricaño-Ponce I; Riza AL; de Nooijer AH; Pirvu A; Dorobantu S; Dragos A; Streata I; Roskanovic M; Grondman I; Dumitrescu F; Kumar V; Netea MG; Ioana M
    BMC Infect Dis; 2022 Oct; 22(1):778. PubMed ID: 36209073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
    Schuurman AR; Reijnders TDY; Saris A; Ramirez Moral I; Schinkel M; de Brabander J; van Linge C; Vermeulen L; Scicluna BP; Wiersinga WJ; Vieira Braga FA; van der Poll T
    Elife; 2021 Aug; 10():. PubMed ID: 34424199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of proteomics in understanding biological mechanisms of sepsis.
    Cao Z; Robinson RA
    Proteomics Clin Appl; 2014 Feb; 8(1-2):35-52. PubMed ID: 24339042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19.
    Martínez-Fleta P; Vera-Tomé P; Jiménez-Fernández M; Requena S; Roy-Vallejo E; Sanz-García A; Lozano-Prieto M; López-Sanz C; Vara A; Lancho-Sánchez Á; Martín-Gayo E; Muñoz-Calleja C; Alfranca A; González-Álvaro I; Galván-Román JM; Aspa J; de la Fuente H; Sánchez-Madrid F
    Front Immunol; 2021; 12():815651. PubMed ID: 35087533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PROGRESS - prospective observational study on hospitalized community acquired pneumonia.
    Ahnert P; Creutz P; Scholz M; Schütte H; Engel C; Hossain H; Chakraborty T; Bauer M; Kiehntopf M; Völker U; Hammerschmidt S; Loeffler M; Suttorp N;
    BMC Pulm Med; 2016 Jul; 16(1):108. PubMed ID: 27535544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.